Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration-Reference-Cited by-同舟云学术

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

Published:2016-05-18 Issue:1 Volume:2 Page:
ISSN:2374-4677
Container-title:npj Breast Cancer
language:en
Short-container-title:npj Breast Cancer

Author:

Leung Samuel C Y, ,Nielsen Torsten O,Zabaglo Lila,Arun Indu,Badve Sunil S,Bane Anita L,Bartlett John M S,Borgquist Signe,Chang Martin C,Dodson Andrew,Enos Rebecca A,Fineberg Susan,Focke Cornelia M,Gao Dongxia,Gown Allen M,Grabau Dorthe,Gutierrez Carolina,Hugh Judith C,Kos Zuzana,Lænkholm Anne-Vibeke,Lin Ming-Gang,Mastropasqua Mauro G,Moriya Takuya,Nofech-Mozes Sharon,Osborne C Kent,Penault-Llorca Frédérique M,Piper Tammy,Sakatani Takashi,Salgado Roberto,Starczynski Jane,Viale Giuseppe,Hayes Daniel F,McShane Lisa M,Dowsett Mitch

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology

Link

http://www.nature.com/articles/npjbcancer201614.pdf

Reference26 articles.

1. Lei, Y. et al. The prognostic role of Ki-67/MIB-1 in upper urinary-tract urothelial carcinomas: a systematic review and meta-analysis. J. Endourol. 29, 1302–1308 (2015).

2. Desouki, M. M., Chamberlain, B. K. & Li, Z. The role of immunohistochemistry in the evaluation of gynecologic pathology part 2: a comparative study between two academic institutes. Ann. Diagn. Pathol. 19, 296–300 (2015).

3. Luporsi, E. et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res. Treat. 132, 895–915 (2012).

4. de Azambuja, E. et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br. J. Cancer 96, 1504–1513 (2007).

5. Denkert, C. et al. Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Ann. Oncol. 24, 2786–2793 (2013).

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric analysis for Ki67 assessment in formalin-fixed paraffin-embedded breast cancer tissue;BMC Biology;2024-08-26

2. Peer‐to‐peer validation of Ki‐67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?;APMIS;2024-07

3. Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1);ESMO Open;2024-06

4. MEX3A is a new diagnostic, independent prognostic biomarker and a promising therapeutic target in gliomas;2024-05-13

5. Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR);Histopathology;2024-05-08